JB
Jack Bendheim
Executive ChairmanDirector10% Owner

Jack Bendheim insider trades: Phibro Animal Health (PAHC) stock sales

Executive Chairman, Phibro Animal Health Last trade May 7, 2026 105 Form 4 filings
$24.3M
Sold, last 12 months
26 sales
$0
Bought, last 12 months
0 buys
98
Open-market trades
since 2014
3
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Jack reports to the SEC

Open-market buys and sales

98 trades reported on SEC Form 4, newest first

DateStockTypeValue
May 7, 2026PAHC↓ Sell$1.0M
Apr 30, 2026PAHC↓ Sell$1.1M
Apr 16, 2026PAHC↓ Sell$1.2M
Mar 31, 2026PAHC↓ Sell$757K
Mar 13, 2026PAHC↓ Sell$258K
Feb 26, 2026PAHC↓ Sell$1.1M
Feb 20, 2026PAHC↓ Sell$716K
Feb 18, 2026PAHC↓ Sell$728K
Feb 11, 2026PAHC↓ Sell$3.7M
Feb 5, 2026PAHC↓ Sell$5.4M
Feb 4, 2026PAHC↓ Sell$545K
Jan 30, 2026PAHC↓ Sell$540K
Jan 23, 2026PAHC↓ Sell$50K
Jan 22, 2026PAHC↓ Sell$1.2M
Jan 15, 2026PAHC↓ Sell$570K
Jan 9, 2026PAHC↓ Sell$9K
Jan 7, 2026PAHC↓ Sell$13K
Dec 11, 2025PAHC↓ Sell$235K
Dec 9, 2025PAHC↓ Sell$193K
Dec 4, 2025PAHC↓ Sell$289K
Dec 1, 2025PAHC↓ Sell$296K
Nov 26, 2025PAHC↓ Sell$542K
Nov 20, 2025PAHC↓ Sell$147K
Nov 18, 2025PAHC↓ Sell$467K
Nov 13, 2025PAHC↓ Sell$1.4M
Nov 10, 2025PAHC↓ Sell$1.9M
Nov 5, 2025PAHC↓ Sell$297K
Oct 30, 2025PAHC↓ Sell$437K
Oct 24, 2025PAHC↓ Sell$766K
Oct 20, 2025PAHC↓ Sell$677K
Sep 30, 2025PAHC↓ Sell$834K
Sep 18, 2025PAHC↓ Sell$283K
Sep 11, 2025PAHC↓ Sell$857K
Sep 12, 2018PAHC↓ Sell10b5-1$23K
Sep 6, 2018PAHC↓ Sell10b5-1$943K
Aug 23, 2018PAHC↓ Sell10b5-1$1.5M
Aug 15, 2018PAHC↓ Sell10b5-1$1.5M
Aug 8, 2018PAHC↓ Sell10b5-1$1.5M
Jul 27, 2018PAHC↓ Sell10b5-1$568K
Jul 19, 2018PAHC↓ Sell10b5-1$837K
Jul 11, 2018PAHC↓ Sell10b5-1$1.4M
Jun 29, 2018PAHC↓ Sell10b5-1$1.4M
Jun 21, 2018PAHC↓ Sell10b5-1$1.4M
Jun 13, 2018PAHC↓ Sell10b5-1$1.4M
Jun 7, 2018PAHC↓ Sell10b5-1$1.4M
May 18, 2018PAHC↓ Sell10b5-1$447K
Mar 25, 2018PAHC↓ Sell10b5-1$117K
Mar 15, 2018PAHC↓ Sell10b5-1$961K
Mar 7, 2018PAHC↓ Sell10b5-1$1.4M
Mar 1, 2018PAHC↓ Sell10b5-1$1.4M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other PAHC insiders

Open-market trades in the last 12 months

About Jack Bendheim's insider trades

Jack Bendheim is Executive Chairman at Phibro Animal Health (PAHC). Since Aug 1, 2014, Jack has reported no open-market purchases and 98 sales worth $82.4M on SEC Form 4. In the last 12 months: 26 sales ($24.3M).

18 sales (23% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.

Their filings also include conversions (67 filings), grants and awards (2 filings), other transactions (2 filings), option exercises (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PAHC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.